merged_progeria-dna-base-editing.txt
<question_number>1</question_number>
<answer>N/A</answer>
<other>The article mentions Nicole Gaudelli and Luke Koblan who worked with Dr. Liu on the base editing system, but doesn't specify who is now leading the effort to apply this technology to human patients with progeria.</other>

<question_number>2</question_number>
<answer>N/A</answer>
<other>The article only mentions that the team wants to "start this trial in two years or less" according to Dr. Collins, but does not provide information about the expected timeline for FDA approval after a successful clinical trial.</other>